Thursday, June 23rd, 2016 - WiseGuyReports

 

ACCESS REPORT @ Recent research explores the Oral Antihyperglycemic Drugs Market   

 The diabetes market is estimated to reach over $60 billion a year. And Oral Antihyperglycemic Drugs share over 60% of the market. As the the world's most populous country, China has 11.6% diabetes mellitus patients among adults populations, which make China the most potential region of diabetes market. 
This report studies Oral Antihyperglycemic Drugs in China market, covering USA, Canada and Mexico, focuses on top players in three Regions, with sales, price, revenue and market share in China market, like 
Eli Lilly 
AstraZeneca 
Bayer 
Takeda 
Novo Nordisk 
Pfizer 
Sinofi 
Boehringer-Ingelheim 
HANSOH PHARMA 
HUADONG MEDICINE 
LUYE PHARMA 
HENGRUI PHARMACEUTICAL 
TIPR Pharmaceutical 
PKU HEALTHCARE 
Jiangsu Heng Rui Medicine

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into 
Sensitizers 
Secretagogues 
Alpha-glucosidase inhibitors 
DPP-4 inhibitors

 

 

GET EXCLUSIVE DISCOUNT @ Recent research explores the Oral Antihyperglycemic Drugs Market   

 

COMPANY PROFILE: 4 China Oral Antihyperglycemic Drugs Manufacturers Analysis 
    4.1 Eli Lilly 
      4.1.1 Company Basic Information, Manufacturing Base and Competitors 
      4.1.2 Oral Antihyperglycemic Drugs Product Segment of Eli Lilly 
          4.1.2.1 Jardiance and Price in 2015 and 2016 of Eli Lilly 
          4.1.2.2 Jentadueto and Price in 2015 and 2016 of Eli Lilly 
          4.1.2.3 Synjardy and Price in 2015 and 2016 of Eli Lilly 
          4.1.2.4 Tradjenta and Price in 2015 and 2016 of Eli Lilly 
          4.1.2.5 Trulicity and Price in 2015 and 2016 of Eli Lilly 
      4.1.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Eli Lilly 2015 to 2016 
      4.1.4 Interviewee, Name and Contact 
    4.2 AstraZeneca 
      4.2.1 Company Basic Information, Manufacturing Base and Competitors 
      4.2.2 Oral Antihyperglycemic Drugs Product Segment of AstraZeneca 
          4.2.2.1 Bydureon and Price in 2015 and 2016 of AstraZeneca 
          4.2.2.2 Byetta and Price in 2015 and 2016 of AstraZeneca 
          4.2.2.3 Kombiglyze XR and Price in 2015 and 2016 of AstraZeneca 
          4.2.2.4 Komboglyze and Price in 2015 and 2016 of AstraZeneca 
          4.2.2.5 Onglyza and Price in 2015 and 2016 of AstraZeneca 
          4.2.2.6 Symlin and Price in 2015 and 2016 of AstraZeneca 
          4.2.2.7 XIGDUO XR and Price in 2015 and 2016 of AstraZeneca 
      4.2.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of AstraZeneca 2015 to 2016 
      4.2.4 Interviewee, Name and Contact 
    4.3 Bayer 
      4.3.1 Company Basic Information, Manufacturing Base and Competitors 
      4.3.2 Oral Antihyperglycemic Drugs Product Segment of Bayer 
          4.3.2.1 Glucobay and Price in 2015 and 2016 of Bayer 
      4.3.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Bayer 2015 to 2016 
      4.3.4 Interviewee, Name and Contact 
    4.4 Takeda 
      4.4.1 Company Basic Information, Manufacturing Base and Competitors 
      4.4.2 Oral Antihyperglycemic Drugs Product Segment of Takeda by Type 
          4.4.2.1 ACTOS and Price in 2015 and 2016 of Takeda 
          4.4.2.2 ACTOPLUS MET and Price in 2015 and 2016 of Takeda 
          4.4.2.3 ACTOPLUS MET XR and Price in 2015 and 2016 of Takeda 
          4.4.2.4 DUETACT and Price in 2015 and 2016 of Takeda 
          4.4.2.5 OSENI and Price in 2015 and 2016 of Takeda 
      4.4.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Takeda 2015 to 2016 
      4.4.4 Interviewee, Name and Contact 
    4.5 Novo Nordisk 
      4.5.1 Company Basic Information, Manufacturing Base and Competitors 
      4.5.2 Oral Antihyperglycemic Drugs Product Segment of Novo nordisk by 
          4.5.2.1 Novonorm and Price in 2015 and 2016 of Novo nordisk 
      4.5.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Novo nordisk 2015 to 2016 
      4.5.4 Interviewee, Name and Contact 
    4.6 Pfizer 
      4.6.1 Company Basic Information, Manufacturing Base and Competitors 
      4.6.2 Oral Antihyperglycemic Drugs Product Segment of Pfizer by Type 
          4.6.2.1 Glucotrol XL and Price in 2015 and 2016 of Pfizer 
      4.6.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Pfizer 2015 to 2016 
      4.6.4 Interviewee, Name and Contact 
    4.7 Sinofi 
      4.7.1 Company Basic Information, Manufacturing Base and Competitors 
      4.7.2 Oral Antihyperglycemic Drugs Product Segment of Sinofi 
          4.7.2.1 Sensitizers and Price in 2015 and 2016 of Sinofi 
          4.7.2.2 Secretagogues and Price in 2015 and 2016 of Sinofi 
          4.7.2.3 Alpha-glucosidase inhibitors and Price in 2015 and 2016 of Sinofi 
      4.7.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Sinofi 2015 to 2016 
      4.7.4 Interviewee, Name and Contact 
    4.8 Boehringer-Ingelheim 
      4.8.1 Company Basic Information, Manufacturing Base and Competitors 
      4.8.2 Oral Antihyperglycemic Drugs Product Segment of Boehringer-Ingelheim 
          4.8.2.1 Tradjenta and Price in 2015 and 2016 of Boehringer-Ingelheim 
      4.8.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Boehringer-Ingelheim 2015 to 2016 
      4.8.4 Interviewee, Name and Contact 
    4.9 HANSOH PHARMA 
      4.9.1 Company Basic Information, Manufacturing Base and Competitors 
      4.9.2 Oral Antihyperglycemic Drugs Product Segment of HANSOH PHARMA 
          4.9.2.1 Fulaiyin and Price in 2015 and 2016 of HANSOH PHARMA 
          4.9.2.2 Fulaihe and Price in 2015 and 2016 of HANSOH PHARMA 
          4.9.2.3 Fulaidi and Price in 2015 and 2016 of HANSOH PHARMA 
      4.9.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of HANSOH PHARMA 2015 to 2016 
      4.9.4 Interviewee, Name and Contact 
    4.10 HUADONG MEDICINE 
      4.10.1 Company Basic Information, Manufacturing Base and Competitors 
      4.10.2 Oral Antihyperglycemic Drugs Product Segment of HUADONG MEDICINE 
          4.10.2.1 Kaboping and Price in 2015 and 2016 of HUADONG MEDICINE 
          4.10.2.2 Kashuangping and Price in 2015 and 2016 of HUADONG MEDICINE 
          4.10.2.3 Kafuping and Price in 2015 and 2016 of HUADONG MEDICINE 
          4.10.2.4 Kasiping and Price in 2015 and 2016 of HUADONG MEDICINE 
      4.10.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of HUADONG MEDICINE 2015 to 2016 
      4.10.4 Interviewee, Name and Contact 

 

 

 ...CONTINUED

KNOW MORE WITH SAMPLE REPORT @  Recent research explores the Oral Antihyperglycemic Drugs Market   



Contact Us
Norah Trent
[email protected]
+1 646 845 9349 / +44 208 133 9349
www.wiseguyreports.com

File Library

Contact Profile

WiseGuyReports


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.


Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/

Keywords

Pharmaceutical, Pharmaceutical 2015,2015 Pharmaceutical,Pharmaceutical research reports,Pharmaceutical market research reports,

Categories

Newsrooms

Sharing

More Formats